Thiele, Carol J
- Division of Basic Sciences - Nci (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #721
- Sustained Excellence
- Top 5% Funded
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2008 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$5.1M
Full award amounts, FY2023
Award Records
4
Records listing this PI
Award-Linked Rank
#721
By linked amount among FY2023 PIs
Earliest Year Loaded
2008
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Thiele, Carol J as a PI. Multi-PI records show the full award amount for context.
- $3.4Maward amount
- 1ZIABC010788-17ZIAContact PIRegulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma$894.8Kaward amount
- 1ZIABC012046-03ZIAContact PINeuroblastoma Tumor Microenvironment: tumor growth and immune regulation$569.4Kaward amount
- 1ZIABC010789-17ZIAContact PIPathophysiologic Consequences of Survival Signaling in Neuroblastoma$162.7Kaward amount
Award organization
Organizations that administered FY2023 awards listing Thiele, Carol J as a PI.
FY2023 award administered by Division of Basic Sciences - Nci ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2008First NIH AwardDivision of Basic Sciences - Nci
- 2008$500K Cumulative Funding
- 2008$1M Cumulative Funding
- 2008Entered Top 50% NationallyRanked #6083
- 2009$2M Cumulative Funding
- 2011$5M Cumulative Funding
- 2012Entered Top 25% NationallyRanked #4945
- 2015$10M Cumulative Funding
- 2021$25M Cumulative Funding
- 2021Entered Top 10% NationallyRanked #279
- 2021Entered Top 5% NationallyRanked #279
- 2022Entered Top 1% NationallyRanked #186